Atlas Trials

Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease

Clinical trial NCT06962891 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06962891
Sponsor
Angel Argiles
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Chronic Kidney Disease(CKD)Progression, Disease
Start date
2023-05-02
Primary completion
2026-03-01
Enrollment
213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.